Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease

In a longitudinal cohort study of participants with type 2 diabetes and DKD, higher levels of serum SAA predicted higher risk of death and ESRD. SAA is a promising targetable biomarker for DKD.